Brief: Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
26/02/2024 13:17
Feb 26 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF
SINGLE-ASCENDING DOSE (SAD) COHORTS OF PHASE 1 CLINICAL STUDY OF
BT-600
Source text for Eikon: ID:nGNX4PgvH4
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules